SAN FRANCISCO (TheStreet) -- It's Day One of the 31st annual J.P. Morgan Healthcare Conference. Welcome to TheStreet's live-blog coverage which today will include presentations from Celgene (CELG) , Onyx Pharma (ONXX), Amarin (AMRN) and Biogen Idec (BIIB), just to name a few.
Here's how this live blog is going to (hopefully) work: I will be posting news updates and analysis throughout the day, live from the presentation rooms and breakout (Q&A) sessions. You can also follow me on Twitter, my handle is @adamfeuerstein.
Your best bet is to check back into the live blog several times throughout the day. Feel free to ping me with questions and comments. I'll do my best to respond and keep the live blog as interactive as possible
Here's my planned schedule for Monday, subject to change, of course. All times Eastern and don't ask how I'm going to manage to be in two places at one time. I haven't figured that out yet: 11 am: Celgene12:30 pm: Onyx Pharma
1 pm: Vertex Pharma (VRTX)
1:30 pm: Biomarin (BMRN)
2:30 pm: Amarin
5:30 pm: Biogen Idec and Vivus (VVUS)
6:30 pm: Gilead Sciences and Dendreon (DNDN)
7:30 pm: Medivation (MDVN) and Ariad Pharma (ARIA). -- Reported by Adam Feuerstein in Boston. Follow @AdamFeuerstein
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
